ALKERMES | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
AbbVie USD 18.07B 4.78B 2024-03
Acadia Pharmaceuticals USD 204.74M 16.09M 2024-03
ALKERMES USD 420.75M 392.62M 2024-03
Amgen USD 9.71B 1.24B 2024-03
Biogen USD 1.07B 24.5M 2024-03
BioMarin Pharmaceutical USD 747M 8.13M 2024-03
Bristol-Myers Squibb USD 9.33B 2.13B 2024-03
Eli Lilly USD 2.46B 79.4M 2024-03
Gilead Sciences USD 4.72B 3.71B 2024-03
Intra Cellular Therapies USD 139.82M 7.95M 2024-03
Ionis Pharmaceuticals USD 348.89M 50.38M 2024-03
J&J USD 25.47B 21.97B 2024-03
Malin Corporation EUR 31.5M 142.4M 2023-06
Merck USD 5.58B 3.03B 2024-03
Neurocrine Biosciences USD 396.3M 102.6M 2024-03
Otsuka Holdings JPY 411.62B 101.72B 2024-03
Pfizer USD 719M 2.43B 2024-03
Regeneron Pharmaceuticals USD 2.6B 13.64B 2024-03
Vertex Pharmaceuticals USD 9.16B 1.95B 2024-03



ALKERMES Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.